Literature DB >> 12044238

Soft-tissue sarcoma in childhood and adolescence.

R Beverly Raney1.   

Abstract

This review summarizes and comments on the major articles that have been published in English concerning pediatric soft-tissue sarcomas in the past 2 years. Studies of rhabdomyosarcoma and undifferentiated sarcoma, including late sequelae of treatment; nonrhabdomyosarcomatous soft-tissue sarcoma; and the pathology of soft-tissue sarcomas are included.

Entities:  

Mesh：

Year:  2002        PMID： 12044238     DOI： 10.1007/s11912-002-0004-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  26 in total

1.  Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma.

Authors:  S L Spunt; T E Lobe; A S Pappo; D M Parham; M D Wharam; C Arndt; J R Anderson; W M Crist; C Paidas; E Wiener; R J Andrassy; C L Schwartz
Journal:  J Pediatr Surg       Date:  2000-02       Impact factor: 2.545

2.  Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88.

Authors:  G Cecchetto; M Carli; G Sotti; G Bisogno; P Dall'Igna; C Boglino; C Granata; L Antoniello; M Guglielmi
Journal:  Med Pediatr Oncol       Date:  2000-02

3.  What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?

Authors:  C A Arndt; S S Donaldson; J R Anderson; R J Andrassy; F Laurie; M P Link; R B Raney; H M Maurer; W M Crist
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

4.  Hemangiopericytoma in pediatric ages: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group.

Authors:  A Ferrari; M Casanova; G Bisogno; A Mattke; C Meazza; A Gronchi; G Cecchetto; P Fidani; D Kunz; J Treuner; M Carli
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

5.  Growth hormone and segmental growth in survivors of head and neck embryonal rhabdomyosarcoma.

Authors:  J R Katz; P Bareille; G Levitt; R Stanhope
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

6.  Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.

Authors:  A S Pappo; E Lyden; J Breneman; E Wiener; L Teot; J Meza; W Crist; T Vietti
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

Review 7.  Alveolar soft part sarcoma in children and adolescents: A report from the Soft-Tissue Sarcoma Italian Cooperative Group.

Authors:  M Casanova; A Ferrari; G Bisogno; G Cecchetto; E Basso; B De Bernardi; P Indolfi; F Fossati Bellani; M Carli
Journal:  Ann Oncol       Date:  2000-11       Impact factor: 32.976

8.  High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study.

Authors:  L Lafay-Cousin; P Plouvier; F Méchinaud; P Boutard; O Oberlin
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

9.  Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.

Authors:  L M Smith; J R Anderson; S J Qualman; W M Crist; C N Paidas; L A Teot; A S Pappo; M P Link; H E Grier; E S Wiener; J C Breneman; R B Raney; H M Maurer; S S Donaldson
Journal:  J Clin Oncol       Date:  2001-10-15       Impact factor: 44.544

10.  Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study.

Authors:  R Heyn; A Ragab; R B Raney; F Ruymann; M Tefft; W Lawrence; E Soule; H M Maurer
Journal:  Cancer       Date:  1986-05-01       Impact factor: 6.860
View more
  1 in total

Review 1.  Molecular genetics of pediatric soft tissue tumors: clinical application.

Authors:  Chung-Che Chang; Vinod B Shidham
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.